h2ax  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    Cell Signaling Technology Inc h2ax
    H2ax, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/h2ax/product/Cell Signaling Technology Inc
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    h2ax - by Bioz Stars, 2023-09
    86/100 stars

    Images

    p h2ax  (Cell Signaling Technology Inc)


    Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
    Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    Cell Signaling Technology Inc p h2ax
    P H2ax, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/p h2ax/product/Cell Signaling Technology Inc
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    p h2ax - by Bioz Stars, 2023-09
    86/100 stars

    Images

    p h2ax  (Cell Signaling Technology Inc)


    Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
    Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    Cell Signaling Technology Inc p h2ax
    Combinatorial drug screen identifies DNA-PKI NU7441 and ATMI KU60019 as synergistic sensitizers for CV-B5/F in NSCLC cells. a NCI-H460 cells were seeded in 96-well plates and treated with escalating doses of each of the 30 compounds in the drug screen, either singly or in combination with CV-B5/F (MOI = 0.01). Top 9 candidate drugs for NCI-H460 identified through this screening. DNA-PK DNA-dependent protein kinase, JAK Janus kinase, Akt serine/threonine kinase, ATM ataxia telangiectasia mutated protein, PI3K phosphatidylinositol 3-kinase, CDK cyclin-dependent kinase, HDAC histone deacetylase. b – d NCI-H460, A549 and NCI-H1299 cells treated with escalating titers of CV-B5/F with or without 1 μM NU7441 for 48 h ( n = 3). EC 50 shifts were shown. e , f NCI-H460 cells were treated with NU7441 (1 μM), KU60019 (1 μM), CV-B5/F (MOI = 0.01), NU7441/CV-B5/F or KU60019/CV-B5/F for 24 h, and comet assay was used to assess double-strand breaks (DSBs). Quantification of tail moment was analyzed by OpenComet software ( n = 20). Scale bar, 40 μm. g NCI-H460 cells were exposed to NU7441 (1 μM), CV-B5/F (MOI = 0.01) or a combination as indicated. <t>p-H2AX</t> (a marker of DNA damage response) was determined by western blot. h NCI-H460 cells were exposed to NU7441 (1 μM), CV-B5/F (MOI = 0.01) or a combination as indicated. Structural viral protein VP1 and cleaved-caspase 3 were determined by western blot. i , j NCI-H460 was transfected with mcherry-GFP-LC3B for 24 h, and then treated with 0.01 MOI CV-B5/F, 1 μM NU7441 or a combination with or without 100 μM CQ. The number of autophagosomes and autolysosomes were enumerated for 20 cells at least. One-way ANOVA was used to analyze data. * P < 0.05, **** P < 0.0001, Scale bar, 10 μm
    P H2ax, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/p h2ax/product/Cell Signaling Technology Inc
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    p h2ax - by Bioz Stars, 2023-09
    86/100 stars

    Images

    1) Product Images from "Non-small cell lung cancers (NSCLCs) oncolysis using coxsackievirus B5 and synergistic DNA-damage response inhibitors"

    Article Title: Non-small cell lung cancers (NSCLCs) oncolysis using coxsackievirus B5 and synergistic DNA-damage response inhibitors

    Journal: Signal Transduction and Targeted Therapy

    doi: 10.1038/s41392-023-01603-4

    Combinatorial drug screen identifies DNA-PKI NU7441 and ATMI KU60019 as synergistic sensitizers for CV-B5/F in NSCLC cells. a NCI-H460 cells were seeded in 96-well plates and treated with escalating doses of each of the 30 compounds in the drug screen, either singly or in combination with CV-B5/F (MOI = 0.01). Top 9 candidate drugs for NCI-H460 identified through this screening. DNA-PK DNA-dependent protein kinase, JAK Janus kinase, Akt serine/threonine kinase, ATM ataxia telangiectasia mutated protein, PI3K phosphatidylinositol 3-kinase, CDK cyclin-dependent kinase, HDAC histone deacetylase. b – d NCI-H460, A549 and NCI-H1299 cells treated with escalating titers of CV-B5/F with or without 1 μM NU7441 for 48 h ( n = 3). EC 50 shifts were shown. e , f NCI-H460 cells were treated with NU7441 (1 μM), KU60019 (1 μM), CV-B5/F (MOI = 0.01), NU7441/CV-B5/F or KU60019/CV-B5/F for 24 h, and comet assay was used to assess double-strand breaks (DSBs). Quantification of tail moment was analyzed by OpenComet software ( n = 20). Scale bar, 40 μm. g NCI-H460 cells were exposed to NU7441 (1 μM), CV-B5/F (MOI = 0.01) or a combination as indicated. p-H2AX (a marker of DNA damage response) was determined by western blot. h NCI-H460 cells were exposed to NU7441 (1 μM), CV-B5/F (MOI = 0.01) or a combination as indicated. Structural viral protein VP1 and cleaved-caspase 3 were determined by western blot. i , j NCI-H460 was transfected with mcherry-GFP-LC3B for 24 h, and then treated with 0.01 MOI CV-B5/F, 1 μM NU7441 or a combination with or without 100 μM CQ. The number of autophagosomes and autolysosomes were enumerated for 20 cells at least. One-way ANOVA was used to analyze data. * P < 0.05, **** P < 0.0001, Scale bar, 10 μm
    Figure Legend Snippet: Combinatorial drug screen identifies DNA-PKI NU7441 and ATMI KU60019 as synergistic sensitizers for CV-B5/F in NSCLC cells. a NCI-H460 cells were seeded in 96-well plates and treated with escalating doses of each of the 30 compounds in the drug screen, either singly or in combination with CV-B5/F (MOI = 0.01). Top 9 candidate drugs for NCI-H460 identified through this screening. DNA-PK DNA-dependent protein kinase, JAK Janus kinase, Akt serine/threonine kinase, ATM ataxia telangiectasia mutated protein, PI3K phosphatidylinositol 3-kinase, CDK cyclin-dependent kinase, HDAC histone deacetylase. b – d NCI-H460, A549 and NCI-H1299 cells treated with escalating titers of CV-B5/F with or without 1 μM NU7441 for 48 h ( n = 3). EC 50 shifts were shown. e , f NCI-H460 cells were treated with NU7441 (1 μM), KU60019 (1 μM), CV-B5/F (MOI = 0.01), NU7441/CV-B5/F or KU60019/CV-B5/F for 24 h, and comet assay was used to assess double-strand breaks (DSBs). Quantification of tail moment was analyzed by OpenComet software ( n = 20). Scale bar, 40 μm. g NCI-H460 cells were exposed to NU7441 (1 μM), CV-B5/F (MOI = 0.01) or a combination as indicated. p-H2AX (a marker of DNA damage response) was determined by western blot. h NCI-H460 cells were exposed to NU7441 (1 μM), CV-B5/F (MOI = 0.01) or a combination as indicated. Structural viral protein VP1 and cleaved-caspase 3 were determined by western blot. i , j NCI-H460 was transfected with mcherry-GFP-LC3B for 24 h, and then treated with 0.01 MOI CV-B5/F, 1 μM NU7441 or a combination with or without 100 μM CQ. The number of autophagosomes and autolysosomes were enumerated for 20 cells at least. One-way ANOVA was used to analyze data. * P < 0.05, **** P < 0.0001, Scale bar, 10 μm

    Techniques Used: Histone Deacetylase Assay, Single Cell Gel Electrophoresis, Software, Marker, Western Blot, Transfection

    DNA-PK inhibitors plus CV-B5/F virus-induced irresolvable ER stress-associated apoptosis in NCI-H460 cells. a NCI-H460 was treated with 1 μM NU7441, 10 μM NAC, 0.01 MOI CV-B5/F, or a combination of NU7441 and CV-B5/F with or without 10 μM NAC. Reactive oxygen species (ROS) of each were detected ( n = 3). b Immunoblots of p-DNA-PK, p-ATM and p-H2AX after infection with CV-B5/F (MOI = 0.01) for 0, 12, 24, and 24 h. c – g NCI-H460 was treated with 1 μM NU7441, 0.01 MOI CV-B5/F, or a combination for 24 h. Immunoblots of p-mTOR, p-Akt (Ser 473), and p-Akt (Thr 308) were detected ( c) . ER stress-associated apoptotic pathways, including caspase 12, CHOP (C/EBP-homologous protein), JNK1/2 (Jun N-terminal kinase 1/2) were analyzed by western blot ( d) . Three initiators of ERS, including ATF6, IRE1, and PERK were detected ( e) . Immunoblots of downstream of PERK were detected ( f) . Data of densitometry analysis were shown ( g) . h – j NCI-H460 was treated for CV-B5/F (MOI = 1) with or without STF-083010 (an inhibitor for IRE1, h), AEBSF (an inhibitor for ATF6, i) or GSK2606414 (an inhibitor for PERK, j) for 24 h. Viral titers in supernatant were measured ( n = 3). One-way ANOVA was used to analyze data. * P < 0.05, ** P < 0.01, **** P < 0.0001, ns, not significant
    Figure Legend Snippet: DNA-PK inhibitors plus CV-B5/F virus-induced irresolvable ER stress-associated apoptosis in NCI-H460 cells. a NCI-H460 was treated with 1 μM NU7441, 10 μM NAC, 0.01 MOI CV-B5/F, or a combination of NU7441 and CV-B5/F with or without 10 μM NAC. Reactive oxygen species (ROS) of each were detected ( n = 3). b Immunoblots of p-DNA-PK, p-ATM and p-H2AX after infection with CV-B5/F (MOI = 0.01) for 0, 12, 24, and 24 h. c – g NCI-H460 was treated with 1 μM NU7441, 0.01 MOI CV-B5/F, or a combination for 24 h. Immunoblots of p-mTOR, p-Akt (Ser 473), and p-Akt (Thr 308) were detected ( c) . ER stress-associated apoptotic pathways, including caspase 12, CHOP (C/EBP-homologous protein), JNK1/2 (Jun N-terminal kinase 1/2) were analyzed by western blot ( d) . Three initiators of ERS, including ATF6, IRE1, and PERK were detected ( e) . Immunoblots of downstream of PERK were detected ( f) . Data of densitometry analysis were shown ( g) . h – j NCI-H460 was treated for CV-B5/F (MOI = 1) with or without STF-083010 (an inhibitor for IRE1, h), AEBSF (an inhibitor for ATF6, i) or GSK2606414 (an inhibitor for PERK, j) for 24 h. Viral titers in supernatant were measured ( n = 3). One-way ANOVA was used to analyze data. * P < 0.05, ** P < 0.01, **** P < 0.0001, ns, not significant

    Techniques Used: Virus, Western Blot, Infection

    Inhibiting DNA-PK or ATM enhances oncolytic therapy in BALB/c nude models of NCI-H460 xenografts. a , b NCI-H460 xenografts were treated with vehicle, CV-B5/F (5 × 10 6 TCID 50 , intratumorally injection), NU7441 (10 mg/kg/day, intraperitoneally) or a combination. Blank, n = 5; Vehicle, n = 5; CV-B5/F, n = 5; NU7441, n = 5; NU7441 + CV-B5/F, n = 5. Tumor growth presented as the mean tumor volume ± SEM ( a) . Images of tumors from each group in ( a ) at the experimental endpoints ( b) . c, d NCI-H460 xenografts were treated with vehicle, CV-B5/F (5 × 10 6 TCID50, intratumorally injection), KU60019 (10 mg/kg/day, intraperitoneally) or a combination. Blank, n = 5; Vehicle, n = 5; CV-B5/F, n = 5; KU60019, n = 5; KU60019 + CV-B5/F, n = 5. Tumor growth presented as the mean tumor volume ± SEM ( c) . Images of tumors from each group in ( c ) at the experimental endpoints ( d) . e – g Tumor tissues from B ( e) or D ( f) were evaluated through IHC for Ki-67 (a marker of proliferation), p-H2AX, cleaved-caspase-3, cleaved-PARP, p-JNK, CV-B5/F, HMGB1. One-way ANOVA was used to analyze data ( n = 20). * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001, Scale bar, 100 μm
    Figure Legend Snippet: Inhibiting DNA-PK or ATM enhances oncolytic therapy in BALB/c nude models of NCI-H460 xenografts. a , b NCI-H460 xenografts were treated with vehicle, CV-B5/F (5 × 10 6 TCID 50 , intratumorally injection), NU7441 (10 mg/kg/day, intraperitoneally) or a combination. Blank, n = 5; Vehicle, n = 5; CV-B5/F, n = 5; NU7441, n = 5; NU7441 + CV-B5/F, n = 5. Tumor growth presented as the mean tumor volume ± SEM ( a) . Images of tumors from each group in ( a ) at the experimental endpoints ( b) . c, d NCI-H460 xenografts were treated with vehicle, CV-B5/F (5 × 10 6 TCID50, intratumorally injection), KU60019 (10 mg/kg/day, intraperitoneally) or a combination. Blank, n = 5; Vehicle, n = 5; CV-B5/F, n = 5; KU60019, n = 5; KU60019 + CV-B5/F, n = 5. Tumor growth presented as the mean tumor volume ± SEM ( c) . Images of tumors from each group in ( c ) at the experimental endpoints ( d) . e – g Tumor tissues from B ( e) or D ( f) were evaluated through IHC for Ki-67 (a marker of proliferation), p-H2AX, cleaved-caspase-3, cleaved-PARP, p-JNK, CV-B5/F, HMGB1. One-way ANOVA was used to analyze data ( n = 20). * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001, Scale bar, 100 μm

    Techniques Used: Injection, Marker

    γ h2ax primary antibody  (Cell Signaling Technology Inc)


    Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
    Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    Cell Signaling Technology Inc γ h2ax primary antibody
    (A) Time-lapse series of anaphase in U2OS CENP-A-GFP/mCherry-α-tubulin cells treated with 100 nM SiR-DNA for 2 h. Scale bar 10 μm. (B) Quantification of percentage of severe chromatin bridges with centromeres marked by CENP-A found in central spindle in anaphase. P -values were calculated using t test. ** P ≤ 0.001. (C) Schematic illustration for correlative microscopy protocol. IF, immunofluorescence; ON, overnight. (D) Time-lapse series of control and SiR-DNA–treated U2OS H2B-GFP cells (left panel). After the live-cell imaging, cells were fixed and correlative immunofluorescence of DNA damage marker <t>γ-H2AX</t> was performed (right panel). Scale bars 10 μm. (E) Quantification of the number of γ-H2AX foci per nucleus upon SiR-DNA treatment. n.s., not significant, **** P < 0.0001.
    γ H2ax Primary Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/γ h2ax primary antibody/product/Cell Signaling Technology Inc
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    γ h2ax primary antibody - by Bioz Stars, 2023-09
    86/100 stars

    Images

    1) Product Images from "SiR-DNA/SiR–Hoechst-induced chromosome entanglement generates severe anaphase bridges and DNA damage"

    Article Title: SiR-DNA/SiR–Hoechst-induced chromosome entanglement generates severe anaphase bridges and DNA damage

    Journal: Life Science Alliance

    doi: 10.26508/lsa.202302260

    (A) Time-lapse series of anaphase in U2OS CENP-A-GFP/mCherry-α-tubulin cells treated with 100 nM SiR-DNA for 2 h. Scale bar 10 μm. (B) Quantification of percentage of severe chromatin bridges with centromeres marked by CENP-A found in central spindle in anaphase. P -values were calculated using t test. ** P ≤ 0.001. (C) Schematic illustration for correlative microscopy protocol. IF, immunofluorescence; ON, overnight. (D) Time-lapse series of control and SiR-DNA–treated U2OS H2B-GFP cells (left panel). After the live-cell imaging, cells were fixed and correlative immunofluorescence of DNA damage marker γ-H2AX was performed (right panel). Scale bars 10 μm. (E) Quantification of the number of γ-H2AX foci per nucleus upon SiR-DNA treatment. n.s., not significant, **** P < 0.0001.
    Figure Legend Snippet: (A) Time-lapse series of anaphase in U2OS CENP-A-GFP/mCherry-α-tubulin cells treated with 100 nM SiR-DNA for 2 h. Scale bar 10 μm. (B) Quantification of percentage of severe chromatin bridges with centromeres marked by CENP-A found in central spindle in anaphase. P -values were calculated using t test. ** P ≤ 0.001. (C) Schematic illustration for correlative microscopy protocol. IF, immunofluorescence; ON, overnight. (D) Time-lapse series of control and SiR-DNA–treated U2OS H2B-GFP cells (left panel). After the live-cell imaging, cells were fixed and correlative immunofluorescence of DNA damage marker γ-H2AX was performed (right panel). Scale bars 10 μm. (E) Quantification of the number of γ-H2AX foci per nucleus upon SiR-DNA treatment. n.s., not significant, **** P < 0.0001.

    Techniques Used: Microscopy, Immunofluorescence, Live Cell Imaging, Marker

    Summary of the quantifications, number of cells, and experiments.
    Figure Legend Snippet: Summary of the quantifications, number of cells, and experiments.

    Techniques Used:

    p γ h2ax  (Cell Signaling Technology Inc)


    Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
    Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    Cell Signaling Technology Inc p γ h2ax
    P γ H2ax, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/p γ h2ax/product/Cell Signaling Technology Inc
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    p γ h2ax - by Bioz Stars, 2023-09
    86/100 stars

    Images

    dna damage marker phospho h2ax  (Cell Signaling Technology Inc)


    Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
    Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    Cell Signaling Technology Inc dna damage marker phospho h2ax
    Biodistribution and mechanistic analyses on the effects of MSLN-TTC as monotherapy or in combination with chemotherapies in ST206B ovarian PDX tumors. Mechanistic analyses were conducted by IHC for necrosis, <t>DNA</t> damage, cell death and angiogenesis. A, Biodistribution of MSLN-TTC in tumor, blood, and selected organs 168 and 336 h after administration of MSLN-TTC in the human ovarian cancer PDX model ST206B. The mice were treated with MSLN-TTC (a single dose, 250 kBq/kg, i.v.) as monotherapy or in combination with the angiogenesis inhibitors regorafenib (30 mg/kg, QD, p.o.) or bevacizumab (5 mg/kg, Q5D, i.v.; n = 3/group). The values are presented as a percentage of remaining thorium-227 activity per injected gram of MSLN-TTC (ID%/g). B, Percentage of necrotic area as determined with Ki67 staining in ST206B tumor samples from mice treated with vehicle, non-radiolabeled MSLN antibody-chelate conjugate (a single dose, 0.43 mg/kg, i.v.), MSLN-TTC (a single dose, 250 kBq/kg, i.v.), docetaxel (7.5 mg/kg, Q7Dx9, i.v.), pegylated liposomal doxorubicin (5 mg/kg, Q7Dx9, i.v.), regorafenib (15 mg/kg, QDx63, p.o.), or bevacizumab (5 mg/kg, Q5Dx13, i.v.) as monotherapies or in combinations as indicated. Total antibody dose was 0.43 mg/kg. C, Nuclei positive for <t>γH2AX</t> in ST206B tumor samples from mice described in B . D, Ki67-positive nuclei in ST206B tumor samples from mice described in B . E, Number of CD31 and α-SMA positive vessels in ST206B tumor samples from mice described in B . Statistical analysis in A was performed using a linear model estimated with generalized least squares that included a common variance parameter for all study groups. Mean comparisons between the treatment and control groups were performed using the estimated model and corrected for family-wise error rate using Sidak method. No statistical significance was found. Statistical analysis in B – E was performed using ANOVA and Dunnett's test. *, P < 0.05; **, P < 0.01; ***, P < 0.001 in comparison to vehicle.
    Dna Damage Marker Phospho H2ax, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/dna damage marker phospho h2ax/product/Cell Signaling Technology Inc
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    dna damage marker phospho h2ax - by Bioz Stars, 2023-09
    86/100 stars

    Images

    1) Product Images from "A Targeted Thorium-227 Conjugate Demonstrates Efficacy in Preclinical Models of Acquired Drug Resistance and Combination Potential with Chemotherapeutics and Antiangiogenic Therapies"

    Article Title: A Targeted Thorium-227 Conjugate Demonstrates Efficacy in Preclinical Models of Acquired Drug Resistance and Combination Potential with Chemotherapeutics and Antiangiogenic Therapies

    Journal: Molecular Cancer Therapeutics

    doi: 10.1158/1535-7163.MCT-22-0808

    Biodistribution and mechanistic analyses on the effects of MSLN-TTC as monotherapy or in combination with chemotherapies in ST206B ovarian PDX tumors. Mechanistic analyses were conducted by IHC for necrosis, DNA damage, cell death and angiogenesis. A, Biodistribution of MSLN-TTC in tumor, blood, and selected organs 168 and 336 h after administration of MSLN-TTC in the human ovarian cancer PDX model ST206B. The mice were treated with MSLN-TTC (a single dose, 250 kBq/kg, i.v.) as monotherapy or in combination with the angiogenesis inhibitors regorafenib (30 mg/kg, QD, p.o.) or bevacizumab (5 mg/kg, Q5D, i.v.; n = 3/group). The values are presented as a percentage of remaining thorium-227 activity per injected gram of MSLN-TTC (ID%/g). B, Percentage of necrotic area as determined with Ki67 staining in ST206B tumor samples from mice treated with vehicle, non-radiolabeled MSLN antibody-chelate conjugate (a single dose, 0.43 mg/kg, i.v.), MSLN-TTC (a single dose, 250 kBq/kg, i.v.), docetaxel (7.5 mg/kg, Q7Dx9, i.v.), pegylated liposomal doxorubicin (5 mg/kg, Q7Dx9, i.v.), regorafenib (15 mg/kg, QDx63, p.o.), or bevacizumab (5 mg/kg, Q5Dx13, i.v.) as monotherapies or in combinations as indicated. Total antibody dose was 0.43 mg/kg. C, Nuclei positive for γH2AX in ST206B tumor samples from mice described in B . D, Ki67-positive nuclei in ST206B tumor samples from mice described in B . E, Number of CD31 and α-SMA positive vessels in ST206B tumor samples from mice described in B . Statistical analysis in A was performed using a linear model estimated with generalized least squares that included a common variance parameter for all study groups. Mean comparisons between the treatment and control groups were performed using the estimated model and corrected for family-wise error rate using Sidak method. No statistical significance was found. Statistical analysis in B – E was performed using ANOVA and Dunnett's test. *, P < 0.05; **, P < 0.01; ***, P < 0.001 in comparison to vehicle.
    Figure Legend Snippet: Biodistribution and mechanistic analyses on the effects of MSLN-TTC as monotherapy or in combination with chemotherapies in ST206B ovarian PDX tumors. Mechanistic analyses were conducted by IHC for necrosis, DNA damage, cell death and angiogenesis. A, Biodistribution of MSLN-TTC in tumor, blood, and selected organs 168 and 336 h after administration of MSLN-TTC in the human ovarian cancer PDX model ST206B. The mice were treated with MSLN-TTC (a single dose, 250 kBq/kg, i.v.) as monotherapy or in combination with the angiogenesis inhibitors regorafenib (30 mg/kg, QD, p.o.) or bevacizumab (5 mg/kg, Q5D, i.v.; n = 3/group). The values are presented as a percentage of remaining thorium-227 activity per injected gram of MSLN-TTC (ID%/g). B, Percentage of necrotic area as determined with Ki67 staining in ST206B tumor samples from mice treated with vehicle, non-radiolabeled MSLN antibody-chelate conjugate (a single dose, 0.43 mg/kg, i.v.), MSLN-TTC (a single dose, 250 kBq/kg, i.v.), docetaxel (7.5 mg/kg, Q7Dx9, i.v.), pegylated liposomal doxorubicin (5 mg/kg, Q7Dx9, i.v.), regorafenib (15 mg/kg, QDx63, p.o.), or bevacizumab (5 mg/kg, Q5Dx13, i.v.) as monotherapies or in combinations as indicated. Total antibody dose was 0.43 mg/kg. C, Nuclei positive for γH2AX in ST206B tumor samples from mice described in B . D, Ki67-positive nuclei in ST206B tumor samples from mice described in B . E, Number of CD31 and α-SMA positive vessels in ST206B tumor samples from mice described in B . Statistical analysis in A was performed using a linear model estimated with generalized least squares that included a common variance parameter for all study groups. Mean comparisons between the treatment and control groups were performed using the estimated model and corrected for family-wise error rate using Sidak method. No statistical significance was found. Statistical analysis in B – E was performed using ANOVA and Dunnett's test. *, P < 0.05; **, P < 0.01; ***, P < 0.001 in comparison to vehicle.

    Techniques Used: Activity Assay, Injection, Staining, Comparison

    anti phospho histone h2ax  (Cell Signaling Technology Inc)


    Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
    Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    Cell Signaling Technology Inc anti phospho histone h2ax
    Anti Phospho Histone H2ax, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti phospho histone h2ax/product/Cell Signaling Technology Inc
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    anti phospho histone h2ax - by Bioz Stars, 2023-09
    86/100 stars

    Images

    h2ax  (Cell Signaling Technology Inc)


    Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
    Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    Cell Signaling Technology Inc h2ax
    H2ax, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/h2ax/product/Cell Signaling Technology Inc
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    h2ax - by Bioz Stars, 2023-09
    86/100 stars

    Images

    anti phospho histone h2ax  (Cell Signaling Technology Inc)


    Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
    Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    Cell Signaling Technology Inc anti phospho histone h2ax
    Anti Phospho Histone H2ax, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti phospho histone h2ax/product/Cell Signaling Technology Inc
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    anti phospho histone h2ax - by Bioz Stars, 2023-09
    86/100 stars

    Images

    rabbit anti p h2ax  (Cell Signaling Technology Inc)


    Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
    Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    Cell Signaling Technology Inc rabbit anti p h2ax
    a) Live-cell microscopy imaging of HCT116 cells treated with NOC and ST-401 for 24 h. NOC treatment results in comparable amounts of cell death in mitosis and interphase, while ST-401 treatment results in cells dying more frequently in interphase. Statistics (a). Data are shown as % of total cells from 3 independent experiments (5,500 cells for ST-401 and 7,200 cells for NOC). b-c) HCT116 cells treated for 3 days with the MTAs, harvested, and labeled with PI/annexin V to measure apoptosis and necrosis using flow cytometry. NOC dose-dependently and gradually increases apoptosis levels whereas ST-401 induces an all-or-nothing increase in apoptosis at 300 nM. Statistics (b-c): Data are expressed as mean of 3 independent experiments with >10,000 cells. Ordinary one-way ANOVA analysis. **P<0.01 significantly different from corresponding CTR. d-f) HCT116 cells stained with monodansylcadaverine (MDC) to detect autophagosomes in HCT116 cells treated with vehicle (CTR), NOC (100 nM) or ST-401 (100 nM) for 24 h. Fluorescence microscopy image of HCT116 cells (d). Flow cytometry histogram of MDC fluorescence (e). Quantification of MDC fluorescence by flow cytometry (f). NOC induces autophagy whereas ST-401 does not. Statistics (e-f): Data are expressed as mean ± s.e.m. of n=3 independent experiments. **P<0.01 significantly different from corresponding CTR (Two-way ANOVA followed by Dunnett’s). **P<0.01 significantly different from corresponding CTR. g-h) HCT116 cells were treated vehicle (CTR), NOC (100 nM) or ST-401 (100 nM) for 24 h, immunostained for P-γH2AX and P-P53, imaged by fluorescence microscopy and pixel intensity analyzed. NOC increased the levels of both <t>P-H2AX</t> (g) P-P53 (h) in the nucleus in a concentration-dependent manner, whereas ST-401 only induced such response at higher concentrations. Statistics (g-h): Data are shown as median with 95% CI for 3 independent experiments where 23,000 and 10,000 total cells were measured for ST-401 and NOC, respectively. Ordinary one-way ANOVA analysis. **P<0.01 significantly different from corresponding CTR.
    Rabbit Anti P H2ax, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti p h2ax/product/Cell Signaling Technology Inc
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    rabbit anti p h2ax - by Bioz Stars, 2023-09
    86/100 stars

    Images

    1) Product Images from "Mitosis exit followed by death in interphase prevents the development of polyploid giant cancer cells"

    Article Title: Mitosis exit followed by death in interphase prevents the development of polyploid giant cancer cells

    Journal: bioRxiv

    doi: 10.1101/2023.08.31.555795

    a) Live-cell microscopy imaging of HCT116 cells treated with NOC and ST-401 for 24 h. NOC treatment results in comparable amounts of cell death in mitosis and interphase, while ST-401 treatment results in cells dying more frequently in interphase. Statistics (a). Data are shown as % of total cells from 3 independent experiments (5,500 cells for ST-401 and 7,200 cells for NOC). b-c) HCT116 cells treated for 3 days with the MTAs, harvested, and labeled with PI/annexin V to measure apoptosis and necrosis using flow cytometry. NOC dose-dependently and gradually increases apoptosis levels whereas ST-401 induces an all-or-nothing increase in apoptosis at 300 nM. Statistics (b-c): Data are expressed as mean of 3 independent experiments with >10,000 cells. Ordinary one-way ANOVA analysis. **P<0.01 significantly different from corresponding CTR. d-f) HCT116 cells stained with monodansylcadaverine (MDC) to detect autophagosomes in HCT116 cells treated with vehicle (CTR), NOC (100 nM) or ST-401 (100 nM) for 24 h. Fluorescence microscopy image of HCT116 cells (d). Flow cytometry histogram of MDC fluorescence (e). Quantification of MDC fluorescence by flow cytometry (f). NOC induces autophagy whereas ST-401 does not. Statistics (e-f): Data are expressed as mean ± s.e.m. of n=3 independent experiments. **P<0.01 significantly different from corresponding CTR (Two-way ANOVA followed by Dunnett’s). **P<0.01 significantly different from corresponding CTR. g-h) HCT116 cells were treated vehicle (CTR), NOC (100 nM) or ST-401 (100 nM) for 24 h, immunostained for P-γH2AX and P-P53, imaged by fluorescence microscopy and pixel intensity analyzed. NOC increased the levels of both P-H2AX (g) P-P53 (h) in the nucleus in a concentration-dependent manner, whereas ST-401 only induced such response at higher concentrations. Statistics (g-h): Data are shown as median with 95% CI for 3 independent experiments where 23,000 and 10,000 total cells were measured for ST-401 and NOC, respectively. Ordinary one-way ANOVA analysis. **P<0.01 significantly different from corresponding CTR.
    Figure Legend Snippet: a) Live-cell microscopy imaging of HCT116 cells treated with NOC and ST-401 for 24 h. NOC treatment results in comparable amounts of cell death in mitosis and interphase, while ST-401 treatment results in cells dying more frequently in interphase. Statistics (a). Data are shown as % of total cells from 3 independent experiments (5,500 cells for ST-401 and 7,200 cells for NOC). b-c) HCT116 cells treated for 3 days with the MTAs, harvested, and labeled with PI/annexin V to measure apoptosis and necrosis using flow cytometry. NOC dose-dependently and gradually increases apoptosis levels whereas ST-401 induces an all-or-nothing increase in apoptosis at 300 nM. Statistics (b-c): Data are expressed as mean of 3 independent experiments with >10,000 cells. Ordinary one-way ANOVA analysis. **P<0.01 significantly different from corresponding CTR. d-f) HCT116 cells stained with monodansylcadaverine (MDC) to detect autophagosomes in HCT116 cells treated with vehicle (CTR), NOC (100 nM) or ST-401 (100 nM) for 24 h. Fluorescence microscopy image of HCT116 cells (d). Flow cytometry histogram of MDC fluorescence (e). Quantification of MDC fluorescence by flow cytometry (f). NOC induces autophagy whereas ST-401 does not. Statistics (e-f): Data are expressed as mean ± s.e.m. of n=3 independent experiments. **P<0.01 significantly different from corresponding CTR (Two-way ANOVA followed by Dunnett’s). **P<0.01 significantly different from corresponding CTR. g-h) HCT116 cells were treated vehicle (CTR), NOC (100 nM) or ST-401 (100 nM) for 24 h, immunostained for P-γH2AX and P-P53, imaged by fluorescence microscopy and pixel intensity analyzed. NOC increased the levels of both P-H2AX (g) P-P53 (h) in the nucleus in a concentration-dependent manner, whereas ST-401 only induced such response at higher concentrations. Statistics (g-h): Data are shown as median with 95% CI for 3 independent experiments where 23,000 and 10,000 total cells were measured for ST-401 and NOC, respectively. Ordinary one-way ANOVA analysis. **P<0.01 significantly different from corresponding CTR.

    Techniques Used: Microscopy, Imaging, Labeling, Flow Cytometry, Staining, Fluorescence, Concentration Assay

    Similar Products

  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86
    Cell Signaling Technology Inc h2ax
    H2ax, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/h2ax/product/Cell Signaling Technology Inc
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    h2ax - by Bioz Stars, 2023-09
    86/100 stars
      Buy from Supplier

    86
    Cell Signaling Technology Inc p h2ax
    P H2ax, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/p h2ax/product/Cell Signaling Technology Inc
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    p h2ax - by Bioz Stars, 2023-09
    86/100 stars
      Buy from Supplier

    86
    Cell Signaling Technology Inc γ h2ax primary antibody
    (A) Time-lapse series of anaphase in U2OS CENP-A-GFP/mCherry-α-tubulin cells treated with 100 nM SiR-DNA for 2 h. Scale bar 10 μm. (B) Quantification of percentage of severe chromatin bridges with centromeres marked by CENP-A found in central spindle in anaphase. P -values were calculated using t test. ** P ≤ 0.001. (C) Schematic illustration for correlative microscopy protocol. IF, immunofluorescence; ON, overnight. (D) Time-lapse series of control and SiR-DNA–treated U2OS H2B-GFP cells (left panel). After the live-cell imaging, cells were fixed and correlative immunofluorescence of DNA damage marker <t>γ-H2AX</t> was performed (right panel). Scale bars 10 μm. (E) Quantification of the number of γ-H2AX foci per nucleus upon SiR-DNA treatment. n.s., not significant, **** P < 0.0001.
    γ H2ax Primary Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/γ h2ax primary antibody/product/Cell Signaling Technology Inc
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    γ h2ax primary antibody - by Bioz Stars, 2023-09
    86/100 stars
      Buy from Supplier

    86
    Cell Signaling Technology Inc p γ h2ax
    (A) Time-lapse series of anaphase in U2OS CENP-A-GFP/mCherry-α-tubulin cells treated with 100 nM SiR-DNA for 2 h. Scale bar 10 μm. (B) Quantification of percentage of severe chromatin bridges with centromeres marked by CENP-A found in central spindle in anaphase. P -values were calculated using t test. ** P ≤ 0.001. (C) Schematic illustration for correlative microscopy protocol. IF, immunofluorescence; ON, overnight. (D) Time-lapse series of control and SiR-DNA–treated U2OS H2B-GFP cells (left panel). After the live-cell imaging, cells were fixed and correlative immunofluorescence of DNA damage marker <t>γ-H2AX</t> was performed (right panel). Scale bars 10 μm. (E) Quantification of the number of γ-H2AX foci per nucleus upon SiR-DNA treatment. n.s., not significant, **** P < 0.0001.
    P γ H2ax, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/p γ h2ax/product/Cell Signaling Technology Inc
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    p γ h2ax - by Bioz Stars, 2023-09
    86/100 stars
      Buy from Supplier

    86
    Cell Signaling Technology Inc dna damage marker phospho h2ax
    Biodistribution and mechanistic analyses on the effects of MSLN-TTC as monotherapy or in combination with chemotherapies in ST206B ovarian PDX tumors. Mechanistic analyses were conducted by IHC for necrosis, <t>DNA</t> damage, cell death and angiogenesis. A, Biodistribution of MSLN-TTC in tumor, blood, and selected organs 168 and 336 h after administration of MSLN-TTC in the human ovarian cancer PDX model ST206B. The mice were treated with MSLN-TTC (a single dose, 250 kBq/kg, i.v.) as monotherapy or in combination with the angiogenesis inhibitors regorafenib (30 mg/kg, QD, p.o.) or bevacizumab (5 mg/kg, Q5D, i.v.; n = 3/group). The values are presented as a percentage of remaining thorium-227 activity per injected gram of MSLN-TTC (ID%/g). B, Percentage of necrotic area as determined with Ki67 staining in ST206B tumor samples from mice treated with vehicle, non-radiolabeled MSLN antibody-chelate conjugate (a single dose, 0.43 mg/kg, i.v.), MSLN-TTC (a single dose, 250 kBq/kg, i.v.), docetaxel (7.5 mg/kg, Q7Dx9, i.v.), pegylated liposomal doxorubicin (5 mg/kg, Q7Dx9, i.v.), regorafenib (15 mg/kg, QDx63, p.o.), or bevacizumab (5 mg/kg, Q5Dx13, i.v.) as monotherapies or in combinations as indicated. Total antibody dose was 0.43 mg/kg. C, Nuclei positive for <t>γH2AX</t> in ST206B tumor samples from mice described in B . D, Ki67-positive nuclei in ST206B tumor samples from mice described in B . E, Number of CD31 and α-SMA positive vessels in ST206B tumor samples from mice described in B . Statistical analysis in A was performed using a linear model estimated with generalized least squares that included a common variance parameter for all study groups. Mean comparisons between the treatment and control groups were performed using the estimated model and corrected for family-wise error rate using Sidak method. No statistical significance was found. Statistical analysis in B – E was performed using ANOVA and Dunnett's test. *, P < 0.05; **, P < 0.01; ***, P < 0.001 in comparison to vehicle.
    Dna Damage Marker Phospho H2ax, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/dna damage marker phospho h2ax/product/Cell Signaling Technology Inc
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    dna damage marker phospho h2ax - by Bioz Stars, 2023-09
    86/100 stars
      Buy from Supplier

    86
    Cell Signaling Technology Inc anti phospho histone h2ax
    Biodistribution and mechanistic analyses on the effects of MSLN-TTC as monotherapy or in combination with chemotherapies in ST206B ovarian PDX tumors. Mechanistic analyses were conducted by IHC for necrosis, <t>DNA</t> damage, cell death and angiogenesis. A, Biodistribution of MSLN-TTC in tumor, blood, and selected organs 168 and 336 h after administration of MSLN-TTC in the human ovarian cancer PDX model ST206B. The mice were treated with MSLN-TTC (a single dose, 250 kBq/kg, i.v.) as monotherapy or in combination with the angiogenesis inhibitors regorafenib (30 mg/kg, QD, p.o.) or bevacizumab (5 mg/kg, Q5D, i.v.; n = 3/group). The values are presented as a percentage of remaining thorium-227 activity per injected gram of MSLN-TTC (ID%/g). B, Percentage of necrotic area as determined with Ki67 staining in ST206B tumor samples from mice treated with vehicle, non-radiolabeled MSLN antibody-chelate conjugate (a single dose, 0.43 mg/kg, i.v.), MSLN-TTC (a single dose, 250 kBq/kg, i.v.), docetaxel (7.5 mg/kg, Q7Dx9, i.v.), pegylated liposomal doxorubicin (5 mg/kg, Q7Dx9, i.v.), regorafenib (15 mg/kg, QDx63, p.o.), or bevacizumab (5 mg/kg, Q5Dx13, i.v.) as monotherapies or in combinations as indicated. Total antibody dose was 0.43 mg/kg. C, Nuclei positive for <t>γH2AX</t> in ST206B tumor samples from mice described in B . D, Ki67-positive nuclei in ST206B tumor samples from mice described in B . E, Number of CD31 and α-SMA positive vessels in ST206B tumor samples from mice described in B . Statistical analysis in A was performed using a linear model estimated with generalized least squares that included a common variance parameter for all study groups. Mean comparisons between the treatment and control groups were performed using the estimated model and corrected for family-wise error rate using Sidak method. No statistical significance was found. Statistical analysis in B – E was performed using ANOVA and Dunnett's test. *, P < 0.05; **, P < 0.01; ***, P < 0.001 in comparison to vehicle.
    Anti Phospho Histone H2ax, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti phospho histone h2ax/product/Cell Signaling Technology Inc
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    anti phospho histone h2ax - by Bioz Stars, 2023-09
    86/100 stars
      Buy from Supplier

    86
    Cell Signaling Technology Inc rabbit anti p h2ax
    a) Live-cell microscopy imaging of HCT116 cells treated with NOC and ST-401 for 24 h. NOC treatment results in comparable amounts of cell death in mitosis and interphase, while ST-401 treatment results in cells dying more frequently in interphase. Statistics (a). Data are shown as % of total cells from 3 independent experiments (5,500 cells for ST-401 and 7,200 cells for NOC). b-c) HCT116 cells treated for 3 days with the MTAs, harvested, and labeled with PI/annexin V to measure apoptosis and necrosis using flow cytometry. NOC dose-dependently and gradually increases apoptosis levels whereas ST-401 induces an all-or-nothing increase in apoptosis at 300 nM. Statistics (b-c): Data are expressed as mean of 3 independent experiments with >10,000 cells. Ordinary one-way ANOVA analysis. **P<0.01 significantly different from corresponding CTR. d-f) HCT116 cells stained with monodansylcadaverine (MDC) to detect autophagosomes in HCT116 cells treated with vehicle (CTR), NOC (100 nM) or ST-401 (100 nM) for 24 h. Fluorescence microscopy image of HCT116 cells (d). Flow cytometry histogram of MDC fluorescence (e). Quantification of MDC fluorescence by flow cytometry (f). NOC induces autophagy whereas ST-401 does not. Statistics (e-f): Data are expressed as mean ± s.e.m. of n=3 independent experiments. **P<0.01 significantly different from corresponding CTR (Two-way ANOVA followed by Dunnett’s). **P<0.01 significantly different from corresponding CTR. g-h) HCT116 cells were treated vehicle (CTR), NOC (100 nM) or ST-401 (100 nM) for 24 h, immunostained for P-γH2AX and P-P53, imaged by fluorescence microscopy and pixel intensity analyzed. NOC increased the levels of both <t>P-H2AX</t> (g) P-P53 (h) in the nucleus in a concentration-dependent manner, whereas ST-401 only induced such response at higher concentrations. Statistics (g-h): Data are shown as median with 95% CI for 3 independent experiments where 23,000 and 10,000 total cells were measured for ST-401 and NOC, respectively. Ordinary one-way ANOVA analysis. **P<0.01 significantly different from corresponding CTR.
    Rabbit Anti P H2ax, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti p h2ax/product/Cell Signaling Technology Inc
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    rabbit anti p h2ax - by Bioz Stars, 2023-09
    86/100 stars
      Buy from Supplier

    Image Search Results


    (A) Time-lapse series of anaphase in U2OS CENP-A-GFP/mCherry-α-tubulin cells treated with 100 nM SiR-DNA for 2 h. Scale bar 10 μm. (B) Quantification of percentage of severe chromatin bridges with centromeres marked by CENP-A found in central spindle in anaphase. P -values were calculated using t test. ** P ≤ 0.001. (C) Schematic illustration for correlative microscopy protocol. IF, immunofluorescence; ON, overnight. (D) Time-lapse series of control and SiR-DNA–treated U2OS H2B-GFP cells (left panel). After the live-cell imaging, cells were fixed and correlative immunofluorescence of DNA damage marker γ-H2AX was performed (right panel). Scale bars 10 μm. (E) Quantification of the number of γ-H2AX foci per nucleus upon SiR-DNA treatment. n.s., not significant, **** P < 0.0001.

    Journal: Life Science Alliance

    Article Title: SiR-DNA/SiR–Hoechst-induced chromosome entanglement generates severe anaphase bridges and DNA damage

    doi: 10.26508/lsa.202302260

    Figure Lengend Snippet: (A) Time-lapse series of anaphase in U2OS CENP-A-GFP/mCherry-α-tubulin cells treated with 100 nM SiR-DNA for 2 h. Scale bar 10 μm. (B) Quantification of percentage of severe chromatin bridges with centromeres marked by CENP-A found in central spindle in anaphase. P -values were calculated using t test. ** P ≤ 0.001. (C) Schematic illustration for correlative microscopy protocol. IF, immunofluorescence; ON, overnight. (D) Time-lapse series of control and SiR-DNA–treated U2OS H2B-GFP cells (left panel). After the live-cell imaging, cells were fixed and correlative immunofluorescence of DNA damage marker γ-H2AX was performed (right panel). Scale bars 10 μm. (E) Quantification of the number of γ-H2AX foci per nucleus upon SiR-DNA treatment. n.s., not significant, **** P < 0.0001.

    Article Snippet: Cells were then incubated with γ-H2AX primary antibody (anti-γ-H2AX, pS139, rabbit polyclonal; Cell Signaling) diluted in PBS-TF at RT for 1 h and washed with PBS for 5 min.

    Techniques: Microscopy, Immunofluorescence, Live Cell Imaging, Marker

    Summary of the quantifications, number of cells, and experiments.

    Journal: Life Science Alliance

    Article Title: SiR-DNA/SiR–Hoechst-induced chromosome entanglement generates severe anaphase bridges and DNA damage

    doi: 10.26508/lsa.202302260

    Figure Lengend Snippet: Summary of the quantifications, number of cells, and experiments.

    Article Snippet: Cells were then incubated with γ-H2AX primary antibody (anti-γ-H2AX, pS139, rabbit polyclonal; Cell Signaling) diluted in PBS-TF at RT for 1 h and washed with PBS for 5 min.

    Techniques:

    Biodistribution and mechanistic analyses on the effects of MSLN-TTC as monotherapy or in combination with chemotherapies in ST206B ovarian PDX tumors. Mechanistic analyses were conducted by IHC for necrosis, DNA damage, cell death and angiogenesis. A, Biodistribution of MSLN-TTC in tumor, blood, and selected organs 168 and 336 h after administration of MSLN-TTC in the human ovarian cancer PDX model ST206B. The mice were treated with MSLN-TTC (a single dose, 250 kBq/kg, i.v.) as monotherapy or in combination with the angiogenesis inhibitors regorafenib (30 mg/kg, QD, p.o.) or bevacizumab (5 mg/kg, Q5D, i.v.; n = 3/group). The values are presented as a percentage of remaining thorium-227 activity per injected gram of MSLN-TTC (ID%/g). B, Percentage of necrotic area as determined with Ki67 staining in ST206B tumor samples from mice treated with vehicle, non-radiolabeled MSLN antibody-chelate conjugate (a single dose, 0.43 mg/kg, i.v.), MSLN-TTC (a single dose, 250 kBq/kg, i.v.), docetaxel (7.5 mg/kg, Q7Dx9, i.v.), pegylated liposomal doxorubicin (5 mg/kg, Q7Dx9, i.v.), regorafenib (15 mg/kg, QDx63, p.o.), or bevacizumab (5 mg/kg, Q5Dx13, i.v.) as monotherapies or in combinations as indicated. Total antibody dose was 0.43 mg/kg. C, Nuclei positive for γH2AX in ST206B tumor samples from mice described in B . D, Ki67-positive nuclei in ST206B tumor samples from mice described in B . E, Number of CD31 and α-SMA positive vessels in ST206B tumor samples from mice described in B . Statistical analysis in A was performed using a linear model estimated with generalized least squares that included a common variance parameter for all study groups. Mean comparisons between the treatment and control groups were performed using the estimated model and corrected for family-wise error rate using Sidak method. No statistical significance was found. Statistical analysis in B – E was performed using ANOVA and Dunnett's test. *, P < 0.05; **, P < 0.01; ***, P < 0.001 in comparison to vehicle.

    Journal: Molecular Cancer Therapeutics

    Article Title: A Targeted Thorium-227 Conjugate Demonstrates Efficacy in Preclinical Models of Acquired Drug Resistance and Combination Potential with Chemotherapeutics and Antiangiogenic Therapies

    doi: 10.1158/1535-7163.MCT-22-0808

    Figure Lengend Snippet: Biodistribution and mechanistic analyses on the effects of MSLN-TTC as monotherapy or in combination with chemotherapies in ST206B ovarian PDX tumors. Mechanistic analyses were conducted by IHC for necrosis, DNA damage, cell death and angiogenesis. A, Biodistribution of MSLN-TTC in tumor, blood, and selected organs 168 and 336 h after administration of MSLN-TTC in the human ovarian cancer PDX model ST206B. The mice were treated with MSLN-TTC (a single dose, 250 kBq/kg, i.v.) as monotherapy or in combination with the angiogenesis inhibitors regorafenib (30 mg/kg, QD, p.o.) or bevacizumab (5 mg/kg, Q5D, i.v.; n = 3/group). The values are presented as a percentage of remaining thorium-227 activity per injected gram of MSLN-TTC (ID%/g). B, Percentage of necrotic area as determined with Ki67 staining in ST206B tumor samples from mice treated with vehicle, non-radiolabeled MSLN antibody-chelate conjugate (a single dose, 0.43 mg/kg, i.v.), MSLN-TTC (a single dose, 250 kBq/kg, i.v.), docetaxel (7.5 mg/kg, Q7Dx9, i.v.), pegylated liposomal doxorubicin (5 mg/kg, Q7Dx9, i.v.), regorafenib (15 mg/kg, QDx63, p.o.), or bevacizumab (5 mg/kg, Q5Dx13, i.v.) as monotherapies or in combinations as indicated. Total antibody dose was 0.43 mg/kg. C, Nuclei positive for γH2AX in ST206B tumor samples from mice described in B . D, Ki67-positive nuclei in ST206B tumor samples from mice described in B . E, Number of CD31 and α-SMA positive vessels in ST206B tumor samples from mice described in B . Statistical analysis in A was performed using a linear model estimated with generalized least squares that included a common variance parameter for all study groups. Mean comparisons between the treatment and control groups were performed using the estimated model and corrected for family-wise error rate using Sidak method. No statistical significance was found. Statistical analysis in B – E was performed using ANOVA and Dunnett's test. *, P < 0.05; **, P < 0.01; ***, P < 0.001 in comparison to vehicle.

    Article Snippet: Western blot analysis was performed using primary antibodies specific for the DNA damage marker phospho-H2AX (γH2AX, #9718, Cell Signaling Technology) and cell death marker cleaved PARP (#9541, Cell Signaling Technology).

    Techniques: Activity Assay, Injection, Staining, Comparison

    a) Live-cell microscopy imaging of HCT116 cells treated with NOC and ST-401 for 24 h. NOC treatment results in comparable amounts of cell death in mitosis and interphase, while ST-401 treatment results in cells dying more frequently in interphase. Statistics (a). Data are shown as % of total cells from 3 independent experiments (5,500 cells for ST-401 and 7,200 cells for NOC). b-c) HCT116 cells treated for 3 days with the MTAs, harvested, and labeled with PI/annexin V to measure apoptosis and necrosis using flow cytometry. NOC dose-dependently and gradually increases apoptosis levels whereas ST-401 induces an all-or-nothing increase in apoptosis at 300 nM. Statistics (b-c): Data are expressed as mean of 3 independent experiments with >10,000 cells. Ordinary one-way ANOVA analysis. **P<0.01 significantly different from corresponding CTR. d-f) HCT116 cells stained with monodansylcadaverine (MDC) to detect autophagosomes in HCT116 cells treated with vehicle (CTR), NOC (100 nM) or ST-401 (100 nM) for 24 h. Fluorescence microscopy image of HCT116 cells (d). Flow cytometry histogram of MDC fluorescence (e). Quantification of MDC fluorescence by flow cytometry (f). NOC induces autophagy whereas ST-401 does not. Statistics (e-f): Data are expressed as mean ± s.e.m. of n=3 independent experiments. **P<0.01 significantly different from corresponding CTR (Two-way ANOVA followed by Dunnett’s). **P<0.01 significantly different from corresponding CTR. g-h) HCT116 cells were treated vehicle (CTR), NOC (100 nM) or ST-401 (100 nM) for 24 h, immunostained for P-γH2AX and P-P53, imaged by fluorescence microscopy and pixel intensity analyzed. NOC increased the levels of both P-H2AX (g) P-P53 (h) in the nucleus in a concentration-dependent manner, whereas ST-401 only induced such response at higher concentrations. Statistics (g-h): Data are shown as median with 95% CI for 3 independent experiments where 23,000 and 10,000 total cells were measured for ST-401 and NOC, respectively. Ordinary one-way ANOVA analysis. **P<0.01 significantly different from corresponding CTR.

    Journal: bioRxiv

    Article Title: Mitosis exit followed by death in interphase prevents the development of polyploid giant cancer cells

    doi: 10.1101/2023.08.31.555795

    Figure Lengend Snippet: a) Live-cell microscopy imaging of HCT116 cells treated with NOC and ST-401 for 24 h. NOC treatment results in comparable amounts of cell death in mitosis and interphase, while ST-401 treatment results in cells dying more frequently in interphase. Statistics (a). Data are shown as % of total cells from 3 independent experiments (5,500 cells for ST-401 and 7,200 cells for NOC). b-c) HCT116 cells treated for 3 days with the MTAs, harvested, and labeled with PI/annexin V to measure apoptosis and necrosis using flow cytometry. NOC dose-dependently and gradually increases apoptosis levels whereas ST-401 induces an all-or-nothing increase in apoptosis at 300 nM. Statistics (b-c): Data are expressed as mean of 3 independent experiments with >10,000 cells. Ordinary one-way ANOVA analysis. **P<0.01 significantly different from corresponding CTR. d-f) HCT116 cells stained with monodansylcadaverine (MDC) to detect autophagosomes in HCT116 cells treated with vehicle (CTR), NOC (100 nM) or ST-401 (100 nM) for 24 h. Fluorescence microscopy image of HCT116 cells (d). Flow cytometry histogram of MDC fluorescence (e). Quantification of MDC fluorescence by flow cytometry (f). NOC induces autophagy whereas ST-401 does not. Statistics (e-f): Data are expressed as mean ± s.e.m. of n=3 independent experiments. **P<0.01 significantly different from corresponding CTR (Two-way ANOVA followed by Dunnett’s). **P<0.01 significantly different from corresponding CTR. g-h) HCT116 cells were treated vehicle (CTR), NOC (100 nM) or ST-401 (100 nM) for 24 h, immunostained for P-γH2AX and P-P53, imaged by fluorescence microscopy and pixel intensity analyzed. NOC increased the levels of both P-H2AX (g) P-P53 (h) in the nucleus in a concentration-dependent manner, whereas ST-401 only induced such response at higher concentrations. Statistics (g-h): Data are shown as median with 95% CI for 3 independent experiments where 23,000 and 10,000 total cells were measured for ST-401 and NOC, respectively. Ordinary one-way ANOVA analysis. **P<0.01 significantly different from corresponding CTR.

    Article Snippet: P-p53 and P-γH2AX were labeled using a mouse anti-P-p53 (1:250, Phospho-p53 (Ser15) (16G8), Cell Signaling Technology) or a rabbit anti-P-H2AX (1:250, Phospho-Histone γH2A.X (Ser139) (20E3), Cell Signaling Technology) applied overnight at 4 °C.

    Techniques: Microscopy, Imaging, Labeling, Flow Cytometry, Staining, Fluorescence, Concentration Assay